SMTL ID : 7dt2.1 (1 other biounit)

Strategic design of catalytic lysine-targeting reversible covalent BCR-ABL Inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x HJ9: [4-[5-[5-(dimethylcarbamoyl)pyridin-3-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-2-methanoyl-5-methoxy-phenyl]boronic acid(Covalent)

HJ9.1: 15 residues within 4Å: Chain A: L.48, G.49, Y.53, V.56, A.69, K.71, T.115, E.116, F.117, M.118, T.119, G.121, N.122, L.170, F.182 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:L.48, A:Y.53, A:V.56, A:V.56, A:A.69, A:K.71, A:L.170, A:L.170, A:F.182 Hydrogen bonds: A:G.49, A:T.115, A:E.116, A:M.118, A:N.122, A:N.122 pi-Stacking: A:F.182

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Quach, D. et al., Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors*. Angew.Chem.Int.Ed.Engl. (2021)

Release Date

2021-06-09

Peptides

Tyrosine-protein kinase ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase ABL1

Related Entries With Identical Sequence